Pharmaceuticals

Olanzapine Market Size and Demand Forecast 2026–2030

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the olanzapine market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Olanzapine Market between 2026 and 2030?

The olanzapine market has experienced consistent expansion in recent times. Its value is projected to rise from $2.63 billion in 2025 to $2.71 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 2.8%. This historic growth can be attributed to several factors, including the increasing prevalence of schizophrenia and bipolar disorder, the early clinical efficacy of atypical antipsychotics, physician preference for broad-spectrum antipsychotics, the expansion of hospital-based psychiatric care, and favorable reimbursement for mental health drugs.

The olanzapine market is projected to experience consistent expansion over the upcoming years. By 2030, its value is anticipated to reach $3.11 billion, showing a compound annual growth rate (CAGR) of 3.6%. This anticipated growth throughout the forecast period stems from factors such as heightened global mental health awareness, an increase in the uptake of combination drug treatments, wider availability of psychiatric care in developing nations, advancements in olanzapine formulations, and a stronger emphasis on patient adherence to treatment. Key trends during this period are expected to encompass an uptick in the use of long-acting injectable olanzapine, a greater inclination towards orally disintegrating tablets, the broadening of combination therapies for bipolar disorder, increased market penetration of generic versions in developing regions, and a move towards managing mental health conditions in home settings.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10748&type=smp

Which Drivers Are Expected To Impact The Olanzapine Market During The Forecast Period?

The expanding occurrence of emotional illness and mental troubles is anticipated to stimulate the expansion of the olanzapine market. Emotional illness and mental trouble refer to conditions or disorders that affect an individual’s mental and emotional well-being. The heightened prevalence of these issues is fueling the demand for mental health treatment solutions, including olanzapine, an atypical antipsychotic predominantly utilized for conditions such as schizophrenia and bipolar disorder, and it may also be prescribed alongside other medications for the treatment of depression. For instance, in May 2024, the American Psychiatric Association, a US-based professional organization, reported that the share of adults experiencing increased anxiety rose from 32% in 2022 to 37% in 2023, reaching 43% in 2024. Consequently, the increasing prevalence of emotional illness and mental troubles is driving the growth of the olanzapine market.

Which Segments Are Driving Activity In The Olanzapine Market?

The olanzapine market covered in this report is segmented –

1) By Therapy Type: Monotherapy, Combinational Therapy

2) By Route Of Administration: Oral, Parenteral

3) By Application: Schizophrenia, Bipolar Disorder, Other Applications

4) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Monotherapy: Tablet Formulation, Orally Disintegrating Tablets, Injectable Formulation

2) By Combinational Therapy: Olanzapine + Fluoxetine, Olanzapine + Other Antipsychotics, Olanzapine + Mood Stabilizers, Olanzapine + Antidepressants

Which Market Trends Are Opening Growth Opportunities In The Olanzapine Market?

Leading companies in the olanzapine market are adopting a strategic partnership approach to introduce the olanzapine drug to the market, aiming for it to be the first long-acting drug with a favorable safety profile. These strategic partnerships involve companies leveraging each other’s strengths and resources to achieve mutual benefits and success. For instance, in November 2023, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, partnered with Royalty Pharma PLC, a US-based biopharmaceutical company. This partnership aims to further accelerate the clinical research program for Teva’s olanzapine LAI (TEV-‘749), a once-monthly subcutaneous long-acting injection of the atypical antipsychotic olanzapine that is currently in Phase 3 for the treatment of schizophrenia.

Which Leading Companies Dominate The Olanzapine Market Share?

Major companies operating in the olanzapine market are Aurobindo Pharma Ltd., Teva Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Limited, Torrent Group, Apotex Inc., Mylan N.V., Viatris Inc., Zydus Cadila Healthcare Ltd., Endo International plc, Lupin Limited, Cipla Inc., Eli Lilly and Company, Zhejiang Langhua Pharmaceutical Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Sandoz International GmbH, Changzhou Huasheng Pharmaceutical Co. Ltd., Par Pharmaceutical, Jubilant Pharmova Limited, Hansoh Pharmaceutical, Egis Pharmaceuticals plc, Actavis Group hf., Hexal AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

How Does The Olanzapine Market Perform Across Major Global Regions?

North America was the largest region in the olanzapine market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global olanzapine market report during the forecast period. The regions covered in the olanzapine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Olanzapine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10748&type=smp

Browse Through More Reports Similar to the Global Olanzapine Market 2026, By The Business Research Company

Olanzapine Market Report 2026

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

Antipsychotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report

Epilepsy Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/epilepsy-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795